Arrakis Therapeutics Company

Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.
Technology: Biopharma, Biotechnology, Medical, Pharmaceutical
Industry: Early Drug Development
Headquarters: Waltham, Massachusetts, United States
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 14
Total Funding: 113000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-04-18
Last Funding Type: Series B

Visit Website
Register and Claim Ownership